Results 11 to 20 of about 73,182 (252)
Targeting cytotoxic lymphocyte antigen 4 (CTLA-4) in breast cancer
Breast cancer (BC) has a high mortality rate and is one of the most common malignancies in the world. Initially, BC was considered non-immunogenic, but a paradigm shift occurred with the discovery of tumor-infiltrating lymphocytes (TILs) and regulatory T
Maryam Jama +2 more
doaj +3 more sources
Background/Objectives: Sporotrichosis is an emerging zoonotic subcutaneous fungal infection with limited therapeutic options, highlighting the need for improved immunomodulatory strategies.
Giovanna Justino Momente +8 more
doaj +4 more sources
Autoimmune disorders such as Hashimoto’s thyroiditis lack curative treatments, only therapeutic agents that treat symptoms very broadly and dampen the entire immune system, including healthy cells.
Vinayan Tiruvellore, Mike Koegle
doaj +3 more sources
Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches [PDF]
Minor histocompatibility antigen (miHA) mismatches have been related to graft-versus-host disease (GVHD) after allogeneic stem cell transplantation, but this association remains controversial due to the lack of consistency in the results obtained by different groups. The CTLA-4 genotype of the donor has been reported to be relevant in the appearance of
David Gallardo +17 more
openaire +8 more sources
CTLA-4 Blockade Enhances the CTL Responses to the p53 Self-Tumor Antigen [PDF]
Abstract p53 is an attractive target for cancer immunotherapy because it is overexpressed in a high proportion of many different types of tumors. However, it is also expressed in normal tissues and acts as a toleragen in vivo. Previously, detailed examination of the repertoire specific for the murine p53261–269 epitope in conventional ...
J, Hernández, A, Ko, L A, Sherman
openaire +2 more sources
CTLA-4 is a second receptor for the B cell activation antigen B7. [PDF]
Functional interactions between T and B lymphocytes are necessary for optimal activation of an immune response. Recently, the T lymphocyte receptor CD28 was shown to bind the B7 counter-receptor on activated B lymphocytes, and subsequently to costimulate interleukin 2 production and T cell proliferation.
P S, Linsley +5 more
openaire +2 more sources
Antigen Exposure during Enhanced CTLA-4 Expression Promotes Allograft Tolerance In Vivo [PDF]
Abstract The role of CTLA-4 in tolerance is primarily inferred from knockout and blocking studies. Anti-CD45RB mediates allograft tolerance in mice by inducing CTLA-4 expression on CD4 cells, providing a novel opportunity to determine how therapeutic enhancement of CTLA-4 promotes tolerance.
Paolo R O, Salvalaggio +6 more
openaire +2 more sources
Background: CTLA-4 (Cytotoxic T Lymphocyte associated Antigen 4, CD152) has been known as a homologue of CD28, an accessory molecule providing a key costimulatory signal for successful antigen-driven activations of T lymphocyte. Most of biochemical and cell biological characteristics of the CD152 protein remain unknown while those of CD28 have been ...
Dae Cheol Rhim, Yong Hoon Chung
openaire +1 more source
Cooperative Roles of CTLA-4 and Regulatory T Cells in Tolerance to an Islet Cell Antigen [PDF]
Adoptive transfer of ovalbumin (OVA)-specific T cells from the DO.11 TCR transgenic mouse on a Rag−/− background into mice expressing OVA in pancreatic islet cells induces acute insulitis and diabetes only if endogenous lymphocytes, including regulatory T cells, are removed.
Eggena, Mark P. +5 more
openaire +2 more sources
Targeting cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) [PDF]
Abstract Cancer immunotherapy centers on modulating the host's tumor‐directed immune response. One promising approach involves augmentation of cell‐mediated immunity by interrupting T‐cell pathways responsible for immune down‐regulation or tolerance.
Steven J, O'Day +2 more
openaire +2 more sources

